AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Nabriva Therapeutics plc

$0 +$0.00 (+0.00%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0 - $0
Year Range
$0$0
Market Cap
323
AVG Volume
53
Trailing/Forward PE
-0/0
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
2026-11-13
Primary Exchange
Other OTCUS
Revenue (USD)
05M10M15M21 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
NBRVF Revenue (USD) by quarter
PeriodRevenue (USD)
23 Q22.57M
23 Q17.59M
22 Q410.44M
22 Q38.78M
22 Q28.78M
22 Q17.67M
21 Q48.91M
21 Q38.42M
21 Q27.75M
21 Q12.13M
Net Income (USD)
-30M-20M-10M021 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
NBRVF Net Income (USD) by quarter
PeriodNet Income (USD)
23 Q2-12.06M
23 Q1-8.7M
22 Q4-22.78M
22 Q3-11.51M
22 Q2-11.07M
22 Q1-11.82M
21 Q4-13.06M
21 Q3-10.65M
21 Q2-11.75M
21 Q1-13.98M
Operating Income (USD)
-30M-20M-10M021 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
NBRVF Operating Income (USD) by quarter
PeriodOperating Income (USD)
23 Q2-12.02M
23 Q1-8.47M
22 Q4-22.33M
22 Q3-11.2M
22 Q2-10.4M
22 Q1-11.56M
21 Q4-12.88M
21 Q3-10.81M
21 Q2-11.38M
21 Q1-13.45M
EBITDA (USD)
-30M-20M-10M021 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
NBRVF EBITDA (USD) by quarter
PeriodEBITDA (USD)
23 Q2-12.01M
23 Q1-8.48M
22 Q4-22.3M
22 Q3-10.81M
22 Q2-10.32M
22 Q1-11.17M
21 Q4-13.28M
21 Q3-10.6M
21 Q2-10.71M
21 Q1-13.3M
Cash Flows (USD)
-30M-20M-10M010M21 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
NBRVF Cash Flows (USD) by quarter
PeriodCash Flows (USD)
23 Q2511K
23 Q1-5.62M
22 Q4-1.63M
22 Q3-6.28M
22 Q2-13.1M
22 Q1-15.9M
21 Q4-6.13M
21 Q3-13.24M
21 Q2-18.47M
21 Q1-21.75M
EPS (USD)
-15-10-5021 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
NBRVF EPS (USD) by quarter
PeriodEPS (USD)
23 Q2-3.73
23 Q1-2.72
22 Q4-7.32
22 Q3-4.21
22 Q2-4.38
22 Q1-5.03
21 Q4-5.89
21 Q3-5.27
21 Q2-7.24
21 Q1-13.23
Expenses (USD)
-5M05M10M15M20MR&DSG&ACapex21 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
NBRVF Expenses (USD) by quarter
PeriodExpenses (USD)
23 Q25.19M
23 Q111.63M
22 Q412.24M
22 Q316.04M
22 Q215.2M
22 Q116.25M
21 Q416.89M
21 Q315.48M
21 Q215.9M
21 Q116.03M
Cash & Debt (USD)
020M40M60M80MCashLong Term DebtShort Term Debt21 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
NBRVF Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
23 Q22.18M
23 Q11.8M
22 Q412.41M
22 Q314.65M
22 Q220.04M
22 Q133.78M
21 Q447.67M
21 Q352.01M
21 Q261.16M
21 Q154.8M
Debt ratios
00.250.50.75121 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
NBRVF Debt ratios by quarter
PeriodDebt ratios
23 Q20.03
23 Q10.02
22 Q40.13
22 Q30.19
22 Q20.28
22 Q10.56
21 Q40.83
21 Q30.85
21 Q20.99
21 Q10.81
Margins
-300%-200%-100%0%100%21 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
NBRVF Margins by quarter
PeriodMargins
23 Q2-252.53%
23 Q141.53%
22 Q4-56.61%
22 Q349.73%
22 Q249.24%
22 Q156.17%
21 Q440.9%
21 Q350.13%
21 Q253.3%
21 Q197.09%
Return on Capital
-750%-500%-250%0%250%21 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
NBRVF Return on Capital by quarter
PeriodReturn on Capital
23 Q273.9%
23 Q1199.68%
22 Q4-691.71%
22 Q3-44.94%
22 Q2-32%
22 Q1-26.49%
21 Q4-24.49%
21 Q3-16.83%
21 Q2-16.99%
21 Q1-25.42%
Shares Outstanding
01M2M3M4M21 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
NBRVF Shares Outstanding by quarter
PeriodShares Outstanding
23 Q23.23M
23 Q13.2M
22 Q43.11M
22 Q32.73M
22 Q22.53M
22 Q12.35M
21 Q42.22M
21 Q32.02M
21 Q21.62M
21 Q11.06M
Book Value Per Share (USD)
-20020406021 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
NBRVF Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
23 Q2-5.05
23 Q1-1.36
22 Q41.06
22 Q39.38
22 Q213.68
22 Q118.97
21 Q424.04
21 Q331.32
21 Q242.64
21 Q152.03
Total Assets (USD)
025M50M75M100M21 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
NBRVF Total Assets (USD) by quarter
PeriodTotal Assets (USD)
23 Q210.58M
23 Q124.34M
22 Q431.77M
22 Q348.24M
22 Q254.89M
22 Q165.78M
21 Q480.91M
21 Q389.12M
21 Q295.41M
21 Q179.41M
Employee Count
05010015020020152016201720182019202020212022
NBRVF Employee Count by quarter
PeriodEmployee Count
202239
202173
202072
2019162
2018110
201788
201659
201552
Free Cash Flow Yield
-600000000%-400000000%-200000000%0%med -4030950.29%Jan 25May 25Sep 25Jan 26May 26Sep 26
NBRVF Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-4030950.29%
Sep 26-4030950.29%
Aug 26-4030950.29%
Aug 26-4030950.29%
Aug 26-4030950.29%
Aug 26-4030950.29%
Jul 26-4030950.29%
Jul 26-4030950.29%
Jul 26-4030950.29%
Jul 26-4030950.29%
Jul 26-4030950.29%
Jun 26-4030950.29%
Jun 26-4030950.29%
Jun 26-4030950.29%
Jun 26-4030950.29%
May 26-4030950.29%
May 26-4030950.29%
May 26-4030950.17%
May 26-2015475.14%
May 26-2015475.14%
Apr 26-2015475.14%
Apr 26-2015475.14%
Apr 26-2015475.14%
Apr 26-2015475.14%
Mar 26-2015475.14%
Mar 26-2015475.14%
Mar 26-2015475.14%
Mar 26-2015475.14%
Feb 26-2015475.09%
Feb 26-2015475.14%
Feb 26-2015475.14%
Feb 26-2015475.14%
Jan 26-4030950.29%
Jan 26-4030950.29%
Jan 26-4030950.17%
Jan 26-4030950.17%
Jan 26-4030950.29%
Dec 25-4030950.29%
Dec 25-4030950.29%
Dec 25-4030950.17%
Dec 25-4030950.29%
Nov 25-4030950.29%
Nov 25-403095017.02%
Nov 25-4030950.29%
Nov 25-4030950.17%
Oct 25-4030950.29%
Oct 25-4030950.17%
Oct 25-4030950.29%
Oct 25-4030950.17%
Oct 25-4030950.29%
Sep 25-4030950.17%
Sep 25-4030950.29%
Sep 25-4030950.29%
Sep 25-4030950.29%
Aug 25-4030950.29%
Aug 25-4030950.29%
Aug 25-4030950.29%
Aug 25-4030950.17%
Aug 25-4030950.29%
Jul 25-4030950.29%
Jul 25-4030950.29%
Jul 25-4030950.17%
Jul 25-4030950.29%
Jun 25-4030950.29%
Jun 25-4030950.17%
Jun 25-4030950.17%
Jun 25-4030950.29%
May 25-4030950.29%
May 25-4030950.29%
May 25-4030950.29%
May 25-4030950.29%
May 25-4030950.29%
Apr 25-4030950.17%
Apr 25-4030950.29%
Apr 25-4030950.29%
Apr 25-4030950.29%
Mar 25-4030950.29%
Mar 25-4030950.29%
Mar 25-403095017.02%
Mar 25-4030950.29%
Feb 25-4030950.29%
Feb 25-4030950.29%
Feb 25-403095017.02%
Feb 25-4030950.29%
Jan 25-4030950.29%
Jan 25-4030950.29%
Jan 25-4030950.29%
Jan 25-4030950.29%
Jan 25-4030950.29%
Dec 24-403095017.02%
Dec 24-4030950.29%
Dec 24-403095017.02%
Dec 24-4030950.29%
Nov 24-4030950.17%
Nov 24-403095017.02%
Nov 24-4030950.29%
Nov 24-2015475.14%
Nov 24-1343649.99%
Oct 24-2015475.09%
Oct 24-2015475.09%
Price to Sales
00000med 0Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
NBRVF Price to Sales by quarter
PeriodPrice to Sales
Sep 260
Sep 260
Aug 260
Aug 260
Aug 260
Aug 260
Jul 260
Jul 260
Jul 260
Jul 260
Jul 260
Jun 260
Jun 260
Jun 260
Jun 260
May 260
May 260
May 260
May 260
May 260
Apr 260
Apr 260
Apr 260
Apr 260
Mar 260
Mar 260
Mar 260
Mar 260
Feb 260
Feb 260
Feb 260
Feb 260
Jan 260
Jan 260
Jan 260
Jan 260
Jan 260
Dec 250
Dec 250
Dec 250
Dec 250
Nov 250
Nov 250
Nov 250
Nov 250
Oct 250
Oct 250
Oct 250
Oct 250
Oct 250
Sep 250
Sep 250
Sep 250
Sep 250
Aug 250
Aug 250
Aug 250
Aug 250
Aug 250
Jul 250
Jul 250
Jul 250
Jul 250
Jun 250
Jun 250
Jun 250
Jun 250
May 250
May 250
May 250
May 250
May 250
Apr 250
Apr 250
Apr 250
Apr 250
Mar 250
Mar 250
Mar 250
Mar 250
Feb 250
Feb 250
Feb 250
Feb 250
Jan 250
Jan 250
Jan 250
Jan 250
Jan 250
Dec 240
Dec 240
Dec 240
Dec 240
Nov 240
Nov 240
Nov 240
Nov 240
Nov 240
Oct 240
Oct 240
Price to Book
00.511.52med 0.34Aug 21Dec 21Mar 22Jul 22Oct 22Feb 23May 23
NBRVF Price to Book by quarter
PeriodPrice to Book
May 231.84
May 231.62
May 231.62
Apr 231.51
Apr 231.57
Apr 230.16
Apr 230.19
Mar 230.19
Mar 230.19
Mar 230.17
Mar 230.17
Mar 230.18
Feb 230.19
Feb 230.19
Feb 230.2
Feb 230.2
Jan 230.16
Jan 230.17
Jan 230.16
Jan 230.14
Dec 220.2
Dec 220.2
Dec 220.2
Dec 220.21
Dec 220.23
Nov 220.23
Nov 220.24
Nov 220.25
Nov 220.16
Oct 220.18
Oct 220.17
Oct 220.17
Oct 220.19
Sep 220.15
Sep 220.17
Sep 220.28
Sep 220.3
Sep 220.3
Aug 220.31
Aug 220.33
Aug 220.36
Aug 220.34
Jul 220.24
Jul 220.23
Jul 220.25
Jul 220.28
Jul 220.24
Jun 220.26
Jun 220.24
Jun 220.28
Jun 220.27
May 220.26
May 220.25
May 220.3
May 220.34
Apr 220.33
Apr 220.34
Apr 220.38
Apr 220.41
Apr 220.43
Mar 220.38
Mar 220.35
Mar 220.34
Mar 220.34
Feb 220.37
Feb 220.41
Feb 220.39
Feb 220.38
Jan 220.36
Jan 220.37
Jan 220.43
Jan 220.47
Dec 210.48
Dec 210.49
Dec 210.53
Dec 210.54
Dec 210.56
Nov 210.67
Nov 210.73
Nov 210.82
Nov 210.78
Oct 210.67
Oct 210.64
Oct 210.69
Oct 210.65
Oct 210.7
Sep 210.69
Sep 210.67
Sep 210.66
Sep 210.65
Aug 210.62
Aug 210.6
Aug 210.61
Aug 210.69
Jul 210.53
Jul 210.54
Jul 210.54
Jul 210.58
Jul 210.62
Jun 210.68
Nabriva Therapeutics plc
NBRVF
Stockpicker

Video analysis: NBRVF

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.